Trial Summary
What is the purpose of this trial?
Pain assessment in infants and toddlers is quite challenging since children in these populations are nonverbal or preverbal and cannot describe the presence and severity of pain that they perceive. Over the last decade, advances in the field have included the development of behavioral scoring systems for the assessment of acute pain . However, although they have been validated, these commonly used methods of pain assessment are largely subjective and rely on a highly trained observer. An objective continuous measure of pain would be an important addition to standard behavioral painscores which require nurses to monitor the child's behavioral responses.
Research Team
Priti G Dalal, MD, FRCA
Principal Investigator
Milton S. Hershey Medical Center
Eligibility Criteria
This trial is for children aged 0-3 years undergoing palatal repair surgery, who are generally healthy (ASA status 1 or 2). It's not suitable for kids with allergies to anesthetics, sleep apnea, cystic fibrosis, serious health conditions (ASA status ≥3), older than 3 years, on chronic pain treatment or taking painkillers before surgery.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Skin Conductance Monitor (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor
Dr. Robert Harbaugh
Milton S. Hershey Medical Center
Chief Medical Officer since 2024
MD from Penn State College of Medicine
Don McKenna
Milton S. Hershey Medical Center
Chief Executive Officer since 2024
Master’s in Public Administration and Bachelor of Science in Business Administration and Marketing from Long Island University